Winslow Evans & Crocker’s VanEck Biotech ETF BBH Stock Holding History

Winslow Evans & Crocker’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$21K	Buy	+125	New	+$20.6K	﹤0.01%	775
2017 Q3	–	Sell	-325	Closed	-$40.8K	–	1124
2017 Q2	$40.8K	Sell	325 -51	-14%	-$6.15K	0.01%	601
2017 Q1	$44.6K	Hold	376	–	–	0.01%	558
2016 Q4	$40.3K	Hold	376	–	–	0.01%	579
2016 Q3	$43.2K	Hold	376	–	–	0.01%	573
2016 Q2	$38.4K	Sell	376 -99	-21%	-$10.6K	0.01%	577
2016 Q1	$49.2K	Sell	475 -1	-0.2%	-$104	0.01%	508
2015 Q4	$60.3K	Hold	476	–	–	0.02%	495
2015 Q3	$54.3K	Hold	476	–	–	0.02%	498
2015 Q2	$64K	Hold	476	–	–	0.02%	501
2015 Q1	$61.6K	Hold	476	–	–	0.02%	509
2014 Q4	$54.8K	Hold	476	–	–	0.02%	520
2014 Q3	$50.3K	Buy	476 +1	+0.2%	+$101	0.01%	555
2014 Q2	$45.3K	Buy	475 +100	+27%	+$8.96K	0.02%	514
2014 Q1	$34.1K	Buy	375 +325	+650%	+$31.6K	0.01%	559
2013 Q4	$4K	Buy	+50	New	+$4.18K	﹤0.01%	1164

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Winslow Evans & Crocker's BBH Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in VanEck Biotech ETF (BBH) in Q4 2020: 125 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #775 among its holdings. This is a return to the name: Winslow Evans & Crocker previously reported a position in BBH as recently as Q2 2017.

Winslow Evans & Crocker first reported a position in BBH in Q4 2013 and has held it in 16 quarters since. The position peaked at $64K in Q2 2015. 108 funds tracked by Wall St. Rank hold BBH as of Q4 2020.

Winslow Evans & Crocker held 125 shares of VanEck Biotech ETF worth $21K as of Q4 2020.
VanEck Biotech ETF was a new Winslow Evans & Crocker position in Q4 2020.
VanEck Biotech ETF made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #775 holding.
Winslow Evans & Crocker first reported a position in VanEck Biotech ETF in Q4 2013 and has held it in 16 quarters since.
Winslow Evans & Crocker's VanEck Biotech ETF position peaked at $64K in Q2 2015.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.